Disc Medicine, Inc.·4

Apr 15, 4:53 PM ET

Franchi Jean M. 4

Research Summary

AI-generated summary

Updated

Disc Medicine (IRON) CFO Jean M. Franchi Sells Shares

What Happened
Jean M. Franchi, Chief Financial Officer of Disc Medicine (IRON), sold a total of 6,657 shares in open-market transactions on April 13–14, 2026, for aggregate proceeds of roughly $460,834. Breakdown: 400 shares sold on 2026-04-13 at $69.00 each ($27,600) and 6,257 shares sold on 2026-04-14 at a weighted average price of $69.24 ($433,234). These were sales (not purchases), which are commonly routine dispositions.

Key Details

  • Transaction dates and prices:
    • 2026-04-13: 400 shares sold at $69.00 — $27,600
    • 2026-04-14: 6,257 shares sold at a weighted avg $69.24 — $433,234 (reported price range $69.07–$69.43)
  • Total shares sold: 6,657; total proceeds: ~$460,834
  • Filing: Form 4 filed 2026-04-15 (timely relative to the reported transactions)
  • Shares owned after transaction: Not disclosed in the provided Form 4 excerpt
  • Footnotes:
    • Trades were effected pursuant to a Rule 10b5-1 trading plan adopted September 25, 2025 (F1)
    • The 4/14 price is a weighted average; the filer can provide a per-price breakdown on request (F2)

Context
These sales were executed under a pre-established 10b5-1 plan, which is a common mechanism for insiders to schedule trades. Sales do not necessarily indicate a change in outlook; purchases tend to be more indicative of insider confidence. No indication of option exercises, gifts, or tax-withholding in this filing excerpt.